We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
KERENDIA Bayer Australia Ltd
Product name
KERENDIA
Sponsor
Accepted date
Mar-2025
Active ingredients
finerenone
Proposed indication
Kerendia (finerenone) is used to treat adults with heart failure who have a left ventricular ejection fraction (LVEF) of 40% or higher. LVEF is a measue of how much blood your heart's left ventricle pumps out with each beat.
Application type
C (new indication)
Publication date
Mar-2025